Status:

NOT_YET_RECRUITING

Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy

Lead Sponsor:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions:

Pancreatic Cancer, Resected

Diarrhea

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

By 2030, pancreatic cancer is projected to become the second leading cause of cancer-related deaths, with a 5-year survival rate below 10%. Approximately 20% of patients are diagnosed at a borderline ...

Eligibility Criteria

Inclusion

  • Age ≥18 years, regardless of gender.
  • Anticipated survival ≥3 months.
  • Severe post-total pancreatectomy diarrhea (as per HART score).
  • Willing and able to provide written informed consent and complete follow-up assessments.
  • Eastern Cooperative Oncology Group (ECOG) performance status score of 1-3.
  • No use of oral/intravenous broad-spectrum antibiotics within 3 days prior to enrollment.
  • Ability to swallow capsules intact without chewing.
  • Adequate organ function confirmed by screening-phase laboratory tests.

Exclusion

  • Major organ insufficiency/failure, including but not limited to:
  • Cardiac insufficiency or heart failure Renal insufficiency or renal failure Hepatic insufficiency or liver failure
  • Uncontrolled or severe infections.
  • Documented history of:
  • Psychoactive drug abuse Alcoholism Illicit drug use
  • Severe infections complicated by sepsis or septicemia.
  • History of severe allergic reactions or known hypersensitivity to components of liquid live-bacterial enteric-coated capsules.
  • Pregnancy or lactation, or women of childbearing potential refusing contraceptive measures during the 15-week observation period.
  • Gastrointestinal perforation and/or fistulas.
  • Other conditions deemed ineligible by the investigator.

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2028

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06960122

Start Date

May 1 2025

End Date

December 31 2028

Last Update

May 7 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang

Hangzhou, Zhejiang, China